Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.
Infection|January 17, 2023
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trialMatthew G Johnson, Julie M Strizki, Michelle L Brown, et al.
Clinical Trials (London, England)|March 3, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT studyYoseph Caraco, Matthew G Johnson, Joseph A Chiarappa, et al.
Microbiology Spectrum|February 1, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Matthew G Johnson, Julie M Strizki, Erin Jensen, et al.
NEJM Evidence|February 6, 2024
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19José R Arribas, Sanjay Bhagani, Suzana M Lobo, et al.
NEJM Evidence|February 6, 2024
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized AdultsYoseph Caraco, Gordon E Crofoot, Pablo Andres Moncada, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individualsSébastien Bihorel, Youfang Cao, Akshita Chawla, et al.
The New England Journal of Medicine|December 16, 2021
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsAngélica Jayk Bernal, Monica M Gomes da Silva, Dany B Musungaie, et al.
Pageof 4